Royal Bank Of Canada Bristol Myers Squibb CO Transaction History

Royal Bank Of Canada

  • $471 Billion
  • Q3 2024

A detailed history of Royal Bank Of Canada transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Royal Bank Of Canada holds 10,811,331 shares of BMY stock, worth $626 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
10,811,331
Previous 6,837,135 58.13%
Holding current value
$626 Million
Previous $284 Million 97.04%
% of portfolio
0.12%
Previous 0.07%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$39.66 - $51.75 $158 Million - $206 Million
3,974,196 Added 58.13%
10,811,331 $559 Million
Q2 2024

Nov 06, 2024
SELL
$40.25 - $52.99 $4.96 Million - $6.53 Million
-123,168 Reduced 1.77%
6,837,135 $284 Million
Q2 2024

Aug 14, 2024
SELL
$40.25 - $52.99 $40.7 Million - $53.6 Million
-1,011,443 Reduced 12.69%
6,960,303 $289 Million
Q1 2024

Nov 05, 2024
BUY
$47.98 - $54.4 $45.4 Million - $51.5 Million
946,429 Added 13.6%
7,906,732 $429 Million
Q1 2024

May 15, 2024
BUY
$47.98 - $54.4 $54.9 Million - $62.2 Million
1,143,273 Added 16.74%
7,971,746 $432 Million
Q4 2023

Feb 14, 2024
BUY
$48.48 - $57.85 $24.7 Million - $29.5 Million
510,017 Added 8.07%
6,828,473 $350 Million
Q3 2023

Nov 14, 2023
SELL
$57.89 - $64.73 $10.3 Million - $11.5 Million
-177,653 Reduced 2.73%
6,318,456 $367 Million
Q2 2023

Aug 14, 2023
BUY
$63.71 - $70.74 $39 Million - $43.3 Million
612,349 Added 10.41%
6,496,109 $415 Million
Q1 2023

May 15, 2023
SELL
$65.71 - $74.53 $76.6 Million - $86.9 Million
-1,165,523 Reduced 16.53%
5,883,760 $408 Million
Q4 2022

Feb 14, 2023
BUY
$68.48 - $81.09 $75.3 Million - $89.2 Million
1,100,213 Added 18.49%
7,049,283 $507 Million
Q3 2022

Nov 14, 2022
SELL
$0.13 - $76.84 $2,783 - $1.65 Million
-21,409 Reduced 0.36%
5,949,070 $423 Million
Q2 2022

Aug 15, 2022
BUY
$72.62 - $79.98 $1.54 Million - $1.7 Million
21,248 Added 0.36%
5,970,479 $460 Million
Q1 2022

May 16, 2022
SELL
$61.48 - $73.72 $98 Million - $118 Million
-1,594,504 Reduced 21.14%
5,949,231 $434 Million
Q4 2021

Feb 14, 2022
BUY
$53.63 - $62.52 $80.1 Million - $93.4 Million
1,494,326 Added 24.7%
7,543,735 $470 Million
Q3 2021

Nov 15, 2021
SELL
$59.17 - $69.31 $69.1 Million - $80.9 Million
-1,167,278 Reduced 16.17%
6,049,409 $358 Million
Q2 2021

Aug 16, 2021
BUY
$61.91 - $67.42 $447 Million - $487 Million
7,216,687 New
7,216,687 $482 Million

Others Institutions Holding BMY

# of Institutions
2,532
Shares Held
1.47B
Call Options Held
31.6M
Put Options Held
35M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email